Mark S. Cohen, M.D.
Associate Professor of Surgery and Pharmacology
Director of Endocrine Surgery Research
University of Michigan Health Systems
1500 East Medical Center Drive
2920K Taubman Center SPC 5331
Ann Arbor, MI 48109-5331
Dr. Cohen is currently Associate Professor of Surgery and Pharmacology, Associate Chair in the Department of Surgery for Innovation and Entrepreneurship, Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship, and a Principal Investigator in the Translational Oncology Program at the University of Michigan Comprehensive Cancer Center. He received his medical degree from Washington University School of Medicine in St. Louis and completed his general surgery residency as well as a NIH-sponsored fellowship in endocrine and oncologic surgery at Barnes-Jewish Hospital. Before coming to the University of Michigan in 2012, he was Associate Professor of Surgery and Pharmacology and Vice-Chair for Research in the Department of Surgery at the University of Kansas.
His clinical interests include endocrine surgery, specifically thyroid surgery for benign and malignant disease, minimally invasive parathyroid surgery, and adrenalectomy, as well as advanced melanoma surgery including hyperthermic isolated limb perfusion, a program he began here at Michigan in 2013 and is now one of the largest in the nation. He is Boarded by the American Board of Surgery and is a Fellow of the American College of Surgeons.
In addition to his clinical interests, Dr. Cohen has an active basic science and translational research laboratory on the NCRC campus focused on development of new drug treatments for cancer patients. These novel drugs are being evaluated for improving the responses of melanoma, thyroid cancer, head and neck squamous cell cancer, colon cancer, and breast cancer. His research is focused in three main areas of translation:
For Additional Information